Leuprolide acetate 22.5 mg 12-week depot formulation in the treatment of patients with advanced prostate cancer (Q71703281)
Jump to navigation
Jump to search
scientific article published on 01 July 1996
Language | Label | Description | Also known as |
---|---|---|---|
English | Leuprolide acetate 22.5 mg 12-week depot formulation in the treatment of patients with advanced prostate cancer |
scientific article published on 01 July 1996 |
Statements
Leuprolide acetate 22.5 mg 12-week depot formulation in the treatment of patients with advanced prostate cancer (English)
R Sharifi
R C Bruskewitz
M C Gittleman
S D Graham
P B Hudson